Document v6q3LbQabEkjMzkVYYNQ8vDL6

DownloadRandom document
To: John R. Allison Dan E. Gahlon Jay V. Ihlenfeld Gregg M. Larson George H. Millet Fred J. Palensky Richard H. Renner Michael A. Santoro Larry A. Wendling Richard F. Ziegler Larry R. Zobel From: Tom DiPasquale Date: November 17, 2003 Re: FC Meeting - November 11, 2003 ATTORNEY-CLIENT PRIVILEGED ATTORNEY WORK PRODUCT These are the action item s discussed at ou r m eeting on Tuesday, N o v em b er 11 grouped by subject m atter headings. It will be the responsibility o f the FC Core Team to see that these actions are carried out. Science 1. D raft a science strategic plan w h ich includes future research, science policy strategies and resource needs. 2. Sponsor analytical research w ith the goal o f establishing standards. 3. Selective funding o f outside research th ro u g h 3M "g ran t" m oney. 4. Build stronger OUS science representation through third party engagem ents. 5. E stablish and strengthen dialogue w ith E P A 's O R D (Dr. P reuss) and m anagem ent (C. A uer, S. Johnson) and other parties outside E P A w ho w ill be influential in PFO S and PFO A risk assessm ent processes and other science policy m atters affecting F C 's. 6. D evelop a list o f 3M and industry-preferred m em bers for Science A dvisory Panels for PFOS and PFO A risk assessment. 7. C onsider m onitoring o f D alton, G A and other m u n icip alities' drinking w ater for PFOS. 8. H old w orkshop for third party spokespersons and include preparation for Science A dvisory Panel public meetings. C O N F ID E N T IA L - S U B J E C T T O A P R O T E C T IV E O R D E R E N T E R E D IN H EN N E P IN C O U N TY D IS TR IC T C O U R T, NO. 2 7 -C V -10-28862 3M MN04778452 ATTORNEY-CLIENT PRIVILEGED ATTORNEY WORK PRODUCT Regulatory/Political 1. C onsider w orking w ith G overnm ent A ffairs and K. R eed to facilitate M cNerney/Leavitt meeting to discuss a range o f 3M environmental issues, including F C 's. 2. M aintain dialogue w ith key political connections at federal and state levels to keep them current on FC developm ents; update "Political Strategy." 3. R eview historical use o f IR IS review s by international, national, state and local authorities. 4. Prepare and submit final perfluorooctanyl phase-out sum m ary to E PA w hen 3M inventories are substantially expired. 5. R eestablish international reg u la to ry -sc ie n tific -le g a l in frastru ctu re-id en tify resources, responsibilities and relationships to US Core Team. Litigation 1. Seek protective orders as appropriate in litigation. Public Issues Management 1. See item s 1 and 2 in R egulatory section. 2. Establish better understanding o f E W G funding sources. 3. M o n ito r for developm ent o f N G O partnerships. 4. Track agendas for science and regulatory conferences. 5. M o n ito r state legislative/regulatory activities. Business 1. P repare a sum m ary o f existing perfluorooctanyl inventories across 3 M 's business units and consider establishing tim etables for consumption or use of inventories. 2. M aintain dialogue w ith E PA and other regulators on C4 chemistry. 3. C atalog all current 3M C 4 product applications. 4. R eview C4 com m ercialization w ith EH S and/or Enterprise R isk Com m ittees (resource needs, reputational and branding risks, C4 screening criteria for expanded applications, 3M position on fluorinated and persistent chemicals). Issue Management 1. See item 5 in R eg ulatory section. 2. Conduct a resource review for ongoing issue m anagem ent needs. 3. R eshape m anagem ent oversight by separating ongoing FC C ore T eam issue m anagement from Public Issues Com m ittee oversight function; change m eeting schedules accordingly. T JD /lsh 2 C O N F ID E N T IA L - S U B J E C T T O A P R O T E C T IV E O R D E R E N T E R E D IN H EN N E P IN C O U N TY D IS TR IC T C O U R T, NO. 2 7 -C V -10-28862 3M